Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

Thermo Fisher will acquire PPD for $47.50 per share for a total price of $17.4 billion, plus the assumption of approximately $3.5 billion in debt.

Twist Bioscience, Pure Biologics Partner on Antibody Discovery for Immunoncology

Pure Biologics will pay technology access fees for Twist's antibody phage display libraries and milestones payments for any antibodies developed.

NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths

At the AACR Annual Meeting, Sharpless said NCI should focus on improving early screening, access to trials, and development of advanced drugs to realize President Biden's goal of eradicating cancer.

OncoDNA, myNEO Partner to Advance Bespoke mRNA-Based Cancer Vaccines

The two firms will use their sequencing and informatics technologies to develop personalized cancer vaccines targeting patients' unique neoantigens.

Metrion Biosciences Closes £2.7M in Equity Financing

Gresham House Ventures led the investment in Cambridge, UK-based Metrion Biosciences, which specializes in ion channel contract research and drug discovery.

Mar 24, 2021

PrecisionLife Acquires Danish Collaborator GenoKey

Mar 22, 2021

Evotec, Takeda Pharmaceuticals Partner on RNA-Targeting Drug Development

Mar 15, 2021

Drug Discovery Firm Insitro Raises $400M in Series C Round

Mar 09, 2021

MD Anderson, Orionis Biosciences Ink Partnership to Advance, Repurpose Small-Molecule Cancer Drugs

Mar 02, 2021

Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs

Feb 25, 2021

Berkeley Lights Q4 Revenues Rise 31 Percent

Feb 25, 2021

Kronos Bio Doses First Patient in CDK9 Inhibitor Trial With Tempus Performing Sequencing

Feb 24, 2021

Crown Bioscience, Cambridge Quantum Computing Partner on Cancer Biomarker Discovery

Feb 18, 2021

Metabolon Strikes Biomarker Discovery Partnership With Cleveland Clinic

Feb 11, 2021

UCLA Receives $29M Donation for Precision Genomic Medicine

Feb 11, 2021

Cancer Genetics to Sell $17.5M in Common Stock Through Direct Offering

Feb 04, 2021

Sano Genetics, Patients Know Best, BenevolentAI, C4X Discovery Form Ulcerative Colitis Alliance

Jan 13, 2021

Merus Partners With Cancer Centers in Netherlands, Japan to ID Patients for eNRGy Trial

Dec 23, 2020

Arbor Biotechnologies Licenses Gene Editing Tech to Lonza

Dec 21, 2020

Adaptive Biotechnologies, Q2 Solutions Sign Marketing Agreement for ImmunoSeq Assay

Dec 21, 2020

Servier, Celsius Therapeutics Partner to Identify Colorectal Cancer Drug Targets

Dec 16, 2020

Genosity Inks Deal With Gemini Therapeutics to Develop Assay for AMD Clinical Trial Patient Selection

Dec 14, 2020

Hummingbird Biosciences, Tempus Partner to ID Cancer Patients for Anti-HER3 Treatment Trial

Dec 11, 2020

BTIG Initiates Coverage of NeoGenomics With Buy Rating

Nov 19, 2020

PMC Report Outlines Strong Growth, Future Challenges for Personalized Medicine Industry

Premium

The Scan

Mix of Human and Monkey

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

Fetal Tissue Policy Changes Expected

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Sequencing the Zoo

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

Featured White Papers

6 Ways Phenotypic Data Improves Decision-Making in Your Drug Development Program

Discovering Multiple Pathways to Drug Resistance in Melanoma Cells with Single-Cell Proteomics and Single-Cell Metabolomics

Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

Apr

20

Featured Webinar

Analysis of a Wellness Cohort Identifies Markers of Metastatic Cancer Years Prior to Diagnosis

This webinar will discuss a study that sought to identify early biomarkers for cancer by analyzing pre-diagnosis samples from seemingly healthy individuals who were later diagnosed with cancer.

Apr

23

Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function.

Apr

28

Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Integrative Analysis of Single-Cell Omics and Imaging Data

Single-cell omics assays have become essential tools for identifying and characterizing cell types and states of complex tissues. While each single-modality assay reveals distinctive features about the sequenced cells, true multiomics assays are still in the early stage of development.

May

04

Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Transcriptome-Guided Analysis of Highly Multiplexed Immunohistochemistry Images

Recently developed technologies for digital imaging and highly multiplexed immunohistochemistry (mIHC) advancing the field of histology into a quantitative era, allowing for more complex descriptions of tissue architecture.

Menu

Drug Discovery & Development

What's Popular?